Drug
Azelaic Acid 15
Azelaic Acid 15: highest development phase Phase 2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azelaic Acid 15% Gel NCT00408330 | Phase 2 | Seborrheic Dermatitis on the Face |
Latest
No recent events.
Follow Azelaic Acid 15 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.